[go: up one dir, main page]

WO2016085127A3 - 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물 - Google Patents

펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물 Download PDF

Info

Publication number
WO2016085127A3
WO2016085127A3 PCT/KR2015/011218 KR2015011218W WO2016085127A3 WO 2016085127 A3 WO2016085127 A3 WO 2016085127A3 KR 2015011218 W KR2015011218 W KR 2015011218W WO 2016085127 A3 WO2016085127 A3 WO 2016085127A3
Authority
WO
WIPO (PCT)
Prior art keywords
same
ascorbic acid
acid derivative
cosmetic composition
composition containing
Prior art date
Application number
PCT/KR2015/011218
Other languages
English (en)
French (fr)
Other versions
WO2016085127A2 (ko
Inventor
박영준
김정윤
정진교
김형미
조은주
임주혁
송현남
박선경
문원강
장신재
홍승서
Original Assignee
(주)셀트리온
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주)셀트리온 filed Critical (주)셀트리온
Priority to SG11201704321TA priority Critical patent/SG11201704321TA/en
Priority to ES15864076T priority patent/ES2767412T3/es
Priority to CN201580074463.5A priority patent/CN107207566B/zh
Priority to EP15864076.3A priority patent/EP3225620B1/en
Priority to JP2017527922A priority patent/JP6500105B2/ja
Publication of WO2016085127A2 publication Critical patent/WO2016085127A2/ko
Publication of WO2016085127A3 publication Critical patent/WO2016085127A3/ko
Priority to US15/606,628 priority patent/US10239902B2/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/676—Ascorbic acid, i.e. vitamin C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/62—Three oxygen atoms, e.g. ascorbic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/65515—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a five-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/08—Peptides, e.g. proteins, carriers being peptides, polyamino acids, proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H11/00—Compounds containing saccharide radicals esterified by inorganic acids; Metal salts thereof
    • C07H11/04—Phosphates; Phosphites; Polyphosphates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

본 발명은 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 유효성분으로 포함하는 화장료 조성물을 제공한다. 본 발명의 펩타이드가 결합된 아스코르빈산 유도체는 멜라닌 생성 억제를 통한 미백 효과 및 콜라겐 생성 활성화를 통한 주름개선 효과를 동시에 나타내는 이중복합 기능을 가지며, 화장료 조성물에 사용될 수 있다.
PCT/KR2015/011218 2014-11-27 2015-10-22 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물 WO2016085127A2 (ko)

Priority Applications (6)

Application Number Priority Date Filing Date Title
SG11201704321TA SG11201704321TA (en) 2014-11-27 2015-10-22 Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same
ES15864076T ES2767412T3 (es) 2014-11-27 2015-10-22 Derivado estable de ácido ascórbico conjugado con péptido, método de preparación del mismo y composición cosmética que comprende el mismo
CN201580074463.5A CN107207566B (zh) 2014-11-27 2015-10-22 稳定的肽缀合抗坏血酸衍生物、用于制备其的方法和包含其的化妆品组合物
EP15864076.3A EP3225620B1 (en) 2014-11-27 2015-10-22 Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition containing same
JP2017527922A JP6500105B2 (ja) 2014-11-27 2015-10-22 ペプチドが結合された安定したアスコルビン酸誘導体、その製造方法、及びそれを含む化粧料組成物
US15/606,628 US10239902B2 (en) 2014-11-27 2017-05-26 Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR10-2014-0167350 2014-11-27
KR20140167350 2014-11-27

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US15/606,628 Continuation US10239902B2 (en) 2014-11-27 2017-05-26 Stable peptide-conjugated ascorbic acid derivative, method for preparing same, and cosmetic composition comprising same

Publications (2)

Publication Number Publication Date
WO2016085127A2 WO2016085127A2 (ko) 2016-06-02
WO2016085127A3 true WO2016085127A3 (ko) 2016-10-06

Family

ID=56075108

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2015/011218 WO2016085127A2 (ko) 2014-11-27 2015-10-22 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물

Country Status (8)

Country Link
US (1) US10239902B2 (ko)
EP (1) EP3225620B1 (ko)
JP (1) JP6500105B2 (ko)
KR (1) KR101652204B1 (ko)
CN (1) CN107207566B (ko)
ES (1) ES2767412T3 (ko)
SG (1) SG11201704321TA (ko)
WO (1) WO2016085127A2 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018005762A2 (en) * 2016-06-29 2018-01-04 Orasis Medical, Inc. Ascorbic acid-amino acid conjugates and their use in regulation of fluid outflow
JP6875704B2 (ja) * 2018-04-13 2021-05-26 マイクロアルジェコーポレーション株式会社 メラニン生成抑制用組成物、美白用組成物、及び発現抑制用組成物
KR102130701B1 (ko) * 2018-09-27 2020-07-06 주식회사 차메디텍 비타민 c가 결합된 펩타이드 유도체 및 이를 포함하는 조성물
KR102222697B1 (ko) 2019-05-02 2021-03-04 (주)리즈케이 아스코르빈산 함유 화장료 조성물 및 이를 포함하는 화장품
KR102740870B1 (ko) * 2020-08-05 2024-12-12 주식회사 레미바이오 아스코르브산 유도체 및 이를 포함하는 조성물
CN118480032A (zh) * 2021-04-30 2024-08-13 禾美生物科技(浙江)有限公司 抗坏血酸多肽衍生物及其制备方法和应用
KR102726678B1 (ko) 2022-04-20 2024-11-07 주식회사 바른바름 4-알킬레졸시놀을 포함하는 고체지질 나노입자, 이를 포함하는 화장료 조성물 및 화장품
KR102576447B1 (ko) * 2022-11-14 2023-09-08 주식회사 차메디텍 열 안정성이 증대된 비타민 c-펩타이드 유도체 및 이를 포함하는 콜라겐 형성용, 미백용 및/또는 항산화용 조성물
CN116035923B (zh) * 2022-11-19 2024-12-20 陕西佰鸿合成生物科技有限公司 一种含神经酰胺&rgd多肽的纳米乳液及其制备方法和应用

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147188A (en) * 1993-12-08 2000-11-14 Prototek, Inc. α- (1,3- or 1, 2- dicarbonylenol ether methyl ketones as cysteine protease inhibitors
US20020122769A1 (en) * 2001-02-26 2002-09-05 Shuang Liu Ascorbic acid analogs for metalloradiopharmaceuticals
KR20040094302A (ko) * 2003-04-30 2004-11-09 주식회사 펩트론 펩타이드가 결합된 비타민 씨 유도체, 이의 제조방법 및이를 포함하는 조성물
KR100691540B1 (ko) * 2006-06-22 2007-03-12 주식회사 펩트론 펩타이드가 결합된 안정화된 비타민 ｃ 유도체, 이의제조방법 및 이를 함유하는 조성물
KR20090040187A (ko) * 2007-10-20 2009-04-23 재단법인서울대학교산학협력재단 펩타이드가 결합된 아스코르빈산 유도체

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5409693A (en) * 1989-10-12 1995-04-25 Perricone; Nicholas V. Method for treating and preventing sunburn and sunburn damage to the skin
JP2772712B2 (ja) * 1990-11-15 1998-07-09 花王株式会社 アスコルビン酸誘導体及びその製造法
DE19824983C2 (de) * 1997-06-04 2001-06-28 Pacific Corp 2-(3-Aminopropylphosphorsäure)-L-ascorbat, Verfahren zu seiner Herstellung und dieses enthaltende kosmetische Zubereitung zur Aufhellung der Haut
JP2001270816A (ja) * 2000-03-23 2001-10-02 Ichimaru Pharcos Co Ltd 化粧料組成物
AU2002332244A1 (en) * 2002-09-24 2004-04-19 Akita Prefecture Demelanizing agents, beautifying agents, demelanizing compositions and beautifying compositions
WO2007094030A1 (ja) * 2006-02-13 2007-08-23 Sakamoto Bio Co., Ltd. 美白剤
JP5255775B2 (ja) * 2007-03-15 2013-08-07 ピアス株式会社 水性ゲル、皮膚外用剤および化粧料
US9408797B2 (en) * 2011-06-03 2016-08-09 Allergan, Inc. Dermal filler compositions for fine line treatment

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6147188A (en) * 1993-12-08 2000-11-14 Prototek, Inc. α- (1,3- or 1, 2- dicarbonylenol ether methyl ketones as cysteine protease inhibitors
US20020122769A1 (en) * 2001-02-26 2002-09-05 Shuang Liu Ascorbic acid analogs for metalloradiopharmaceuticals
KR20040094302A (ko) * 2003-04-30 2004-11-09 주식회사 펩트론 펩타이드가 결합된 비타민 씨 유도체, 이의 제조방법 및이를 포함하는 조성물
KR100691540B1 (ko) * 2006-06-22 2007-03-12 주식회사 펩트론 펩타이드가 결합된 안정화된 비타민 ｃ 유도체, 이의제조방법 및 이를 함유하는 조성물
KR20090040187A (ko) * 2007-10-20 2009-04-23 재단법인서울대학교산학협력재단 펩타이드가 결합된 아스코르빈산 유도체

Also Published As

Publication number Publication date
US10239902B2 (en) 2019-03-26
SG11201704321TA (en) 2017-06-29
EP3225620A2 (en) 2017-10-04
WO2016085127A2 (ko) 2016-06-02
JP6500105B2 (ja) 2019-04-10
US20170258931A1 (en) 2017-09-14
CN107207566B (zh) 2021-01-22
JP2018509376A (ja) 2018-04-05
ES2767412T3 (es) 2020-06-17
KR101652204B1 (ko) 2016-08-29
KR20160063976A (ko) 2016-06-07
EP3225620A4 (en) 2018-11-07
CN107207566A (zh) 2017-09-26
EP3225620B1 (en) 2019-11-20

Similar Documents

Publication Publication Date Title
WO2016085127A3 (ko) 펩타이드가 결합된 안정한 아스코르빈산 유도체, 그의 제조방법 및 그를 포함하는 화장료 조성물
AU2015336400A8 (en) Novel Aminoalkyl benzothiazepine Derivatives And Uses Thereof
EP3199036A4 (en) Composition, containing tyndallized lactobacillus dead cells as active ingredient, for skin moisturizing or wrinkle improvement
MX389228B (es) Composiciones para tratar el cabello.
EP3127533A4 (en) Melanogenesis inhibitor comprising d-pantothenyl alcohol, and skin-whitening cosmetic containing same melanogenesis inhibitor
WO2015142001A3 (ko) 강심 활성을 갖는 화합물 및 이를 함유하는 심부전 예방 또는 치료용 약학적 조성물
EP3354254A4 (en) SKIN-SHELLING COMPOSITION WITH BETA-MANGOSTINE AS AN ACTIVE SUBSTANCE
HK1248069A1 (zh) 去乙酰氧基微管溶素h及其類似物
MX2020002123A (es) Sales de ribociclib y formas en estado sólido de las mismas.
MY173573A (en) Pyridin-4-yl derivatives
EP3180993A4 (en) Composition for improving skin, containing pomegranate concentrate as active ingredient
EP3424488A4 (en) AQUEOUS COSMETIC COMPOSITION
MX367321B (es) Composición para el cuidado de la piel y métodos para la misma.
WO2016030899A8 (en) Methods of treating amyotrophic lateral scleroses
MX368582B (es) Extracto de gardenia para colorear la piel.
MX2019013250A (es) 2,3,7-trimetiloct-6-enil acetato y 3,7-dimetil-2-metilen-oct-6-eni l acetato y derivados de estos y su uso como sustancias quimicas aromaticas.
EA032472B9 (ru) Композиция для укладки волос
WO2019059511A3 (ko) 3,4-디-카페오일퀴닌산을 포함하는, 활성산소종, 자외선 또는 미세먼지에 대한 피부 보호용 화장료 조성물
IN2014MU01079A (ko)
WO2015144997A8 (fr) Composition cosmetique et/ou dermatologique pour la coloration de la peau
WO2013131756A3 (en) Hair care composition
MX2016014970A (es) Composicion cosmetica antitranspirante y desodorante que tiene accion dermocalmante.
WO2019059512A3 (ko) 푸르푸로갈린을 포함하는, 활성산소종, 자외선 또는 미세먼지에 대한 피부 보호용 화장료 조성물
WO2014128126A3 (fr) Utilisation cosmétique de la queuine
EP3323411A4 (en) Composition for inhibiting angiogenesis containing nanoparticle-vitreous body-based protein complex as active ingredient, and use thereof

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15864076

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2017527922

Country of ref document: JP

Kind code of ref document: A

REEP Request for entry into the european phase

Ref document number: 2015864076

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 11201704321T

Country of ref document: SG

NENP Non-entry into the national phase

Ref country code: DE